Search results for “Primary hyperoxaluria” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 112 patents, we discovered top 16 key players by total patent application. BioMarin Pharmaceutical, Inc., Intellia Therapeutics, Inc., Alnylam Pharmaceuticals, Inc. are dominant in this area. They take 46.43% of the total patent filing.
BioMarin Pharmaceutical, Inc.
California, United States
Patent: 31
Intellia Therapeutics, Inc.
Massachusetts, United States
Patent: 11
Alnylam Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 10
Cantero Therapeutics
California, United States
Patent: 8
STARTUP
Arbor Biotechnologies, Inc.
Massachusetts, United States
Patent: 6
OxThera AB
Sweden
Patent: 6
STARTUP
Sapreme Technologies BV
Utrecht, Netherlands
Patent: 6
Oxthera Intellectual Property AB
Sweden
Patent: 6
UAB Research Foundation
Alabama, United States
Patent: 6
CRISPR Therapeutics AG
Massachusetts, United States
Patent: 3
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 12 patents, we discovered top 2 start-ups by total patent application.
STARTUP
Arbor Biotechnologies, Inc.
Massachusetts, United States
Patent: 6
STARTUP
Sapreme Technologies BV
Utrecht, Netherlands
Patent: 6
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 96 patents applied in the last 5 years. We discover 13 most active companies in this area. The fast-growing BioMarin Pharmaceutical, Inc., Intellia Therapeutics, Inc., Cantero Therapeutics take 52.08% of patent filing during this period.
BioMarin Pharmaceutical, Inc.
California, United States
Patent: 31
Intellia Therapeutics, Inc.
Massachusetts, United States
Patent: 11
Cantero Therapeutics
California, United States
Patent: 8
Alnylam Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 8
STARTUP
Sapreme Technologies BV
Utrecht, Netherlands
Patent: 6
STARTUP
Arbor Biotechnologies, Inc.
Massachusetts, United States
Patent: 6
Regents of the University of California
California, United States
Patent: 4
CRISPR Therapeutics AG
Massachusetts, United States
Patent: 3
Precision BioSciences, Inc.
North Carolina, United States
Patent: 3
Charité - Universitätsmedizin Berlin
Berlin, Germany
Patent: 2
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 96 patents in last 5 years, we discover 11 new entrants. BioMarin Pharmaceutical, Inc., Intellia Therapeutics, Inc., Cantero Therapeutics are the most active new entrants in this area.
BioMarin Pharmaceutical, Inc.
California, United States
Patent: 31
Intellia Therapeutics, Inc.
Massachusetts, United States
Patent: 11
Cantero Therapeutics
California, United States
Patent: 8
STARTUP
Sapreme Technologies BV
Utrecht, Netherlands
Patent: 6
STARTUP
Arbor Biotechnologies, Inc.
Massachusetts, United States
Patent: 6
Regents of the University of California
California, United States
Patent: 4
CRISPR Therapeutics AG
Massachusetts, United States
Patent: 3
Precision BioSciences, Inc.
North Carolina, United States
Patent: 3
Charité - Universitätsmedizin Berlin
Berlin, Germany
Patent: 2
Department of Health & Human Services
Australia
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 11 patents, we discovered top 4 universities and scientific research institutions by total patent application. Charité - Universitätsmedizin Berlin, Vanderbilt University, Fukuoka University are dominant in this area. They take 63.64% of the total patent filing.
Charité - Universitätsmedizin Berlin
Berlin, Germany
Patent: 2
Vanderbilt University
Tennessee, United States
Patent: 1
Fukuoka University
Fukuoka-ken, Japan
Patent: 1
Sorbonne Université
France
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: